
ETMarkets Smart Talk: Sectors to watch in 2H2025 - Defence, Real Estate, Aviation, says Alok Agarwal
Alok Agarwal
, Head – Quant and Fund Manager at Alchemy Capital Management, to discuss the sectoral outlook for the second half of 2025.
Amid improving macro stability, robust earnings momentum, and supportive monetary policy, Agarwal believes India is entering a favourable phase for select high-growth
sectors
.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Join new Free to Play WWII MMO War Thunder
War Thunder
Play Now
Undo
He highlights
defence
,
real estate
,
aviation
, electronic manufacturing, and capital markets as the key themes likely to outperform in 2H2025.
With nominal GDP growth expected to remain in double digits and structural reforms in play, these sectors are well-positioned to deliver earnings well above market averages. Edited Excerpts –
Q) June is turning out to be a volatile month for D-Street. How is 2H2025 likely to pan out for Indian markets? Do you think most of the negatives are behind us?
Live Events
A) June 2025 has been a volatile month, with the Indian stock market experiencing significant fluctuations, led by the global uncertainties, such as the Iran-Israel war, the US trade policies and inflation fears. The FPI flows have been marginally negative too.
However, in our view, the outlook for the second half of 2025 (2H2025) leans towards recovery. The recently concluded Q4FY25 earnings season was fairly strong with
Nifty
500 reporting an aggregate growth of over 11% YoY, and Nifty 500 ex-Nifty 50 reporting growth of over 20% YoY.
Corporate earnings momentum remains intact, macro stability is improving, and liquidity conditions are supportive.
The corporate earnings to GDP ratio is now at a 17-year high, the GST collection growth in May 2025 was the highest since October 2022, the inflation is at over a six-year low, and the
RBI
has been proactively supportive of growth and liquidity.
The RBI's 50 basis points (bps) repo rate cut on June 6, 2025, to 5.5% is a significant catalyst, reducing borrowing costs and stimulating economic activity. Plus, the CRR (Cash Reserve Ratio) has been cut to a record low level of 3.0%.
In our view, the bulk of the negatives are priced in. However, we would be closely following the Iran-Israel war too for any unexpected escalation and its impact on crude oil.
Q) What does 50 bps cut mean for equity and bond markets? What should be an asset allocation strategy?
A) The RBI's 50 bps repo rate cut is a pivotal move to support growth amid low inflation (2.8% in May 2025 – lowest since February 2019).
Falling inflation and rates are positive for both the equity and bond markets. For equity markets, lower interest rates reduce borrowing costs, encouraging investment and consumption, which can boost corporate earnings and stock prices.
Sectors like real estate, infrastructure, and consumer durables are direct beneficiaries of the rate cut, reducing funding costs for banks and stimulating lending. Moreover, falling rates are also positive for valuations.
For bond markets, the rate cut leads to higher bond prices and lower yields, making bonds more attractive for income-seeking investors.
The accompanying 100 bps cut in the Cash Reserve Ratio (CRR) to 3%, releasing ₹2.5 lakh crore in liquidity further supports bond markets.
The policy's stance has shifted to 'neutral,' suggesting the easing cycle may pause, however, the immediate impact is positive for both asset classes.
While we do see a longer runway of growth for equity and limited room for further rate cuts, yet for asset allocation, individual risk-reward requirements could be quite different and hence one should reach out to their investment/financial advisors.
At Alchemy, we are positive on equity and do expect a prolonged period of double-digit nominal GDP growth in India.
Q) What is your take on Q4 earnings from India Inc.? Any hits and misses which you tracked in the results?
A) The aggregate of Nifty 500 Index companies showed a YoY growth of 11.9% in the net profits, higher than estimates of just touching double digits. The break-up is even more interesting:
Agencies
As evident from the above table, the Nifty 50 earnings were a drag on the overall numbers. The broader markets, including the Nifty Next 50, grew at a healthy pace with operating profit growing at 14% YoY and net profit at over 22% YoY.
Index heavyweight sectors saw sluggish growth. Oil & gas -4% YoY, private banks -3% YoY, consumer 4% YoY, technology 3% YoY.
However, with the economic numbers rebounding, the GST collections improving, and multi-year low inflation and rates, the outlook is much brighter.
Q) Nifty Bank hit a record high in June which suggests that there is a lot of interest in banking stocks. What is fuelling the rally in financials – is it the rate cut by RBI?
A) Falling inflation and hence falling interest rates are good for lenders as they reduce funding costs and stimulate lending. Healthy Q4FY25 earnings, with banks performing well despite margin pressures, also contributed to the Nifty Bank's rally.
The sector's resilience, supported by the RBI's easing cycle, reflects investor confidence. The protected margins and strong control over credit costs are aiding the strength.
With inflation at over six-year lows and CRR at record low, there is limited room for more easing via rates and CRR by the RBI.
However, the bank loan growth has fallen to a three-year low of 9.8% YoY (for the fortnight ended May 23, 2025) and deposit growth is also struggling near a two-year low of 10%. When the RBI cut rates, it was a choice between growth and margins for the banks.
Few banks chose to protect margins and cut deposit rates, while others have maintained. It will be interesting to see who wins the battle to mobilise deposits.
Q) Which sectors are likely to remain in limelight in the 2H2025?
A) For 2H2025, several sectors are expected to remain in the limelight, driven by India's structural growth story and policy support.
The sectors that have been growing well include Industrials (led by defence, power), electronic manufacturing companies, capital market plays (exchanges, intermediaries, brokers, AMCs, wealth managers), hospitals, hotels, aviation, real estate and cement.
In a scenario where nominal GDP is expected to be just over double digits, and top index heavy weight sectors' profit growth is struggling to match the nominal GDP growth, the above-mentioned sectors have been reporting profit growth well in excess of nominal GDP growth and more importantly, consensus estimates point towards continued higher growth.
Q) The tonality keeps changing from the US when it comes to 'Trade Talks'. Do you think it is still a relevant headwind for equity markets across the globe?
A) US trade talks, particularly with China, have seen fluctuations, with recent discussions in London in early June 2025 resulting in a framework agreement.
The deal aims to ease tariffs and export controls, but its durability is uncertain, offering little resolution to deeper issues. Market reactions have been cautious, with mixed global sentiments, reflecting ongoing uncertainty.
For India, while direct impact is limited, global economic conditions and FPI flows are affected, keeping trade talks a relevant headwind, though the impact value has substantially reduced.
Q) China equity markets are up in double digits while we have underperformed most EM peers. Does it make a case for global diversification?
A) In USD terms, China's Shanghai Composite Index has delivered 2.7% returns so far this year, compared Nifty 50 Index's 4.1%. While India's index corrected more sharply earlier in the year, the recovery has been sharper too.
India has rare combination of:
Falling dependency ratio for the last 30 years and likely to continue for another 20 years
Double-digit nominal GDP growth
Double-digit corporate earnings growth
Double-digit corporate ROE
Over 500 companies with $1bn plus market cap
Diversified market with good depth across sectors
Per capita income at inflexion point of $2500
Shorter term, notwithstanding, India is set to outperform the world and its neighbours, in our view.
While diversification always makes sense, the better diversification would be an EM (emerging market) basket as compared to a DM (developed market) basket.
Q) Which sector(s) is/are looking overheated and why?
A) Overheated is a relative term. A sector that grows at a fast pace or expected to grow at a fast pace cannot be really compared with the one which is struggling for growth.
Same goes with valuations – PEG (price/earnings to growth) ratios throw more light on reasonableness of valuation as compared to PE alone.
BSE 500 Index trades at a one-year forward PE of 22x and next two years earnings growth is estimated to be at 10%. This translates into a PEG ratio of 2.2x. As a house, our investment framework is built around GARP methodology, which favours Growth at Reasonable Price.
Ideally, if the growth is above market and the PEG is below market, its preferred. But the sectors that have run up, where estimated growth could be lower than market growth and PEG is quite high compared to market – are the sectors which we find overheated. In our view, these include oil & gas, FMCG, IT and select banks.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
10 minutes ago
- Economic Times
US' new tariff list: India at 25%, exports to get hit, competitors in lower band
Synopsis Effective August 7, 2025, the US has imposed a blanket 25% tariff on all Indian-origin goods, placing India among the most harshly treated nations in its new tariff regime. This measure, part of a new Executive Order, denies India product-level exemptions, even for critical sectors like pharmaceuticals and electronics. Agencies US' new tariff list New Delhi: In a move that could dent India's exports to US, Washington has imposed a blanket 25% tariff on all Indian-origin goods, effective August 7, measure, part of a new Executive Order issued by US President Donald Trump on July 31, places India among the most harshly treated countries in the new American tariff regime, offering no product-level exemptions even for sectors deemed critical like pharmaceuticals, energy, and Order mentions that tariffs may be reduced once countries do a deal with the per the order, countries have been subject to tariffs ranging from 10% to over 41% with differential rates based on geopolitical risk, economic alignment, and trade said the new order puts India at disadvantage to majority competitors including Pakistan, Vietnam, Bangladesh, Turkey where the tariffs are 15-20%. 'India's exports of petroleum products, smartphones, pharmaceuticals, engineering goods, electronics, and textiles will bear the brunt of the tariffs,' said a representative of an export promotion penalty threatened by Trump on India for doing business with Russia has not yet been US, Wednesday, announced 25% tariffs on India along with undisclosed penalty on trading with Russia.'The implications of the recent development are being examined by the government. The Ministry of Commerce and Industry is engaged with all stakeholders including exporters and industry for taking feedback of their assessment of the situation,' commerce and industry minister Piyush Goyal said in his statement in Parliament US was India's largest export destination in FY25 with shipments valued at $86.51 billion. But it accounted for less than a fifth of its total goods exports of $437.42 per the Order, unlike many other trading partners, India has been denied all product-level exemptions—even for products and sectors, the US exempted Goods from other tariff exempted categories include finished pharmaceutical drugs, APIsand other key drug inputs; energy products, critical minerals and a wide range of electronics and EU has been granted a special concession in which if the existing US most favoured nation (MFN) tariff on an EU product is below 15%, the total tariff will be increased to 15%. However, if the MFN tariff is already 15% or higher, then no additional duty will be charged.A 10% tariff applies to a few countries—Brazil, the UK, and the Falkland 15% tariff, which is the most common, covers 38 countries. Countries facing higher tariffs (25-30%) include India, Brunei, Kazakhstan, Moldova, and and Serbia at 35%, Switzerland at 39% (unusually high for a developed nation), Laos and Myanmar at 40%, and Syria at 41%, the US Customs Border Protection authority will realise a guidance clarifying on how this measure will be applied.


Hans India
12 minutes ago
- Hans India
Trump asks 17 non-Indian drug majors to cut prices in US; Nifty pharma dips
Mumbai: A letter from US President Donald Trump has asked 17 global drug giants to cut their prices in the country, sparking severe losses for them, as its impact hit the Indian stock market too. The letter urged that these businesses cut US drug pricing to match prices in other developed markets. Though no Indian pharmaceutical companies received Trump's letters, the Nifty Pharma index reacted sharply, falling 2.45 per cent during the intra-day trade on Friday. The index fell for the third day in a row. Sun Pharmaceutical Industries Ltd fell 3.98 per cent. Aurobindo Pharma lost 3.42 per cent and Granules India lost 3.2 per cent. Gland Pharma, Cipla, and Lupin fell 2 to 3 per cent. The US President wrote to 17 of the world's major pharmaceutical corporations, pressing them to lower drug prices immediately and give assurance that future drugs will be priced in line with other countries. The letters were sent to Eli Lilly, Novo Nordisk, Pfizer, and others, seeking 'Most Favoured Nation' (MFN) pricing for US within 60 days. White House Press Secretary Karoline Leavitt said recent data showed that Americans paid more than three times more for brand-name drugs than other developed nations. Trump had earlier made a similar announcement on May 12, asking pharma companies to cut prices in US. Industry sources in India had then said Trump's proposal might hurt Indian exporters of branded generics to the US, given generic drugs are already sold at low prices. If prices are cut further, it will make shipping unviable, they said. A third of Indian pharmaceutical exports of $30 billion annually, reach the US market. Trump gave drug companies 60 days to voluntarily comply with the new pricing diktat in the letter, failing which, he said, the US would use 'every tool in our arsenal' to protect Americans from 'continued abusive drug pricing' practices. Trump's letter required companies to sell certain drugs directly to patients at prices at which they are offered to third-party insurers.
&w=3840&q=100)

First Post
12 minutes ago
- First Post
Indian imports bill could rise buy $14 billion after stopping Russian oil imports
If India were to stop buying Russian crude oil, Indian imports bill could rise by up to $14 billion as a result of expensive imports from elsewhere. But the true impact on India —and Western nations as well— could be larger as India's purchase of Russian oil has kept international prices low so far. read more Fuga Bluemarine crude oil tanker lies at anchor near the terminal Kozmino in Nakhodka Bay near the port city of Nakhodka, Russia. India's imports bill could rise by up to $14 billion after stopping Russian crude oil imports. In addition to slapping India with 25 per cent tariff, US President Donald Trump has threatened additional penalties over the trade with Russia, mainly the purchase of Russian oil — India has bought discounted Russian oil since Russia launched the war on Ukraine in 2022. The true cost of India replacing Russian oil imports in the wake of Trump's threats would be much higher than $14 billion for India and the world. STORY CONTINUES BELOW THIS AD The true cost of replacing Russian oil for India — and the world India stopping the purchase of Russian oil could raise the price of oil by up to $10 per barrel, raising the country's import bill by around $13-14 billion, according to Prashant Vasisht, the Senior Vice President and Co-Group Head of Corporate Ratings at ICRA. Vasisht suggested the true cost could be higher as prices of gas and other petroleum products and derivatives will also rise. 'Additionally, domestic gas and LNG imports linked to dated Brent prices would also become dearer thereby impacting all gas consumers such as fertiliser, city gas distribution etc. A $10/barrel increase in Brent prices could increase the cost of LNG purchased annually under the RasGas contract by Rs 3,900 crore,' Vasisht told The Financial Express. Between May 2022-2025, India saved around $17.2 billion with the purchase of discounted Russian oil, according to ICRA's calculations. However, that may now change — and not just for India. With the purchase of discounted Russian oil, India and China have so far stabilised oil prices in the international market by absorbing Russian over-supply and easing the pressure on global prices. But, if and when India would stop importing Russian oil, the competition for non-Russian oil would rise and prices will rise as demand will rise in proportion to supply. Western nations will also feel the pinch. Firstly, prices of oil will also rise for them owing to greater demand and limited supply of non-Russian oil. Secondly, since 2022, Indian refiners had been processing Russian crude and selling finished products to Western nations at cheaper rates. As such discounted purchases would end, their bills will rise as well.